Alx Oncology Return On Equity vs. Price To Sales

ALXO Stock  USD 16.21  0.74  4.37%   
Based on the key profitability measurements obtained from Alx Oncology's financial statements, Alx Oncology Holdings may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in June. Profitability indicators assess Alx Oncology's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.85)
Current Value
(0.81)
Quarterly Volatility
18.27556635
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Alx Oncology's Price To Sales Ratio is very stable compared to the past year. As of the 12th of May 2024, EV To Sales is likely to grow to 2,399, while Days Sales Outstanding is likely to drop 44.57. At this time, Alx Oncology's Income Quality is very stable compared to the past year.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.07250.0815
Fairly Down
Slightly volatile
For Alx Oncology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Alx Oncology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Alx Oncology Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Alx Oncology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Alx Oncology Holdings over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Alx Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.74)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.39)
Return On Equity
(0.71)
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Alx Oncology Holdings Price To Sales vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Alx Oncology's current stock value. Our valuation model uses many indicators to compare Alx Oncology value to that of its competitors to determine the firm's financial worth.
Alx Oncology Holdings is rated below average in return on equity category among related companies. It is number one stock in price to sales category among related companies . At this time, Alx Oncology's Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Alx Oncology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Alx Oncology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alx Oncology's earnings, one of the primary drivers of an investment's value.

Alx Price To Sales vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Alx Oncology

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.71
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Alx Oncology

P/S

 = 

MV Per Share

Revenue Per Share

 = 
5,906 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Alx Price To Sales Comparison

Alx Oncology is currently under evaluation in price to sales category among related companies.

Alx Oncology Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Alx Oncology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Alx Oncology will eventually generate negative long term returns. The profitability progress is the general direction of Alx Oncology's change in net profit over the period of time. It can combine multiple indicators of Alx Oncology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income256 K268.8 K
Net Interest Income9.1 M9.5 M
Operating Income-170.3 M-161.8 M
Net Loss-160.8 M-152.8 M
Income Before Tax-160.8 M-152.8 M
Total Other Income Expense Net9.5 M9.9 M
Net Loss-111.1 M-105.6 M
Net Loss-160.8 M-152.8 M
Income Tax Expense57.6 K58.1 K
Interest Income10.6 M11.2 M
Non Operating Income Net Other-299 K-313.9 K
Change To Netincome27.4 M28.8 M
Net Loss(3.74)(3.93)
Income Quality 0.81  0.89 
Net Income Per E B T 1.15  1.10 

Alx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Alx Oncology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Alx Oncology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Alx Oncology's important profitability drivers and their relationship over time.

Use Alx Oncology in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alx Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will appreciate offsetting losses from the drop in the long position's value.

Alx Oncology Pair Trading

Alx Oncology Holdings Pair Trading Analysis

The ability to find closely correlated positions to Alx Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alx Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alx Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alx Oncology Holdings to buy it.
The correlation of Alx Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alx Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alx Oncology Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alx Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Alx Oncology position

In addition to having Alx Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Risk ETFs Thematic Idea Now

Target Risk ETFs
Target Risk ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Alx Oncology Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alx Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alx Oncology Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alx Oncology Holdings Stock:
Check out Trending Equities.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Alx Stock analysis

When running Alx Oncology's price analysis, check to measure Alx Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alx Oncology is operating at the current time. Most of Alx Oncology's value examination focuses on studying past and present price action to predict the probability of Alx Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alx Oncology's price. Additionally, you may evaluate how the addition of Alx Oncology to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets
To fully project Alx Oncology's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Alx Oncology Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Alx Oncology's income statement, its balance sheet, and the statement of cash flows.
Potential Alx Oncology investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Alx Oncology investors may work on each financial statement separately, they are all related. The changes in Alx Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alx Oncology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.